CELON PHARMA (Resolution No. 1255/2016)

16-12-2016 12:12

Resolution No. 1255/2016
of the Management Board of the Warsaw Stock Exchange
dated 28 November 2016


concerning the introduction to exchange trading in the GPW Main List of
series A2 and B bearer ordinary shares of the company
CELON PHARMA S.A.


§ 1

Pursuant to § 38.1 and § 38.3 of the Exchange Rules and § 2.1 of Division 4 of the Detailed Exchange Trading Rules in UTP, the Exchange Management Board resolves as follows:

1) to introduce as of 1 December 2016 by way of an ordinary procedure to exchange trading in the main market the following series bearer ordinary shares of the company CELON PHARMA S.A. a par value PLN 0.10 each:

a) 15,000,000 series A2 shares, coded as “PLCLNPH00015” by the National Depository for Securities,
b) 15,000,000 series B shares, conditional on the registration of the series B shares and their coding as “PLCLNPH00015” by the National Depository for Securities on 1 December 2016;

2) to list the shares of the company CELON PHARMA S.A., mentioned in point 1), in the continuous trading system under the abbreviated name „CLNPHARMA” and the code „CLN”.

§ 2

This Resolution shall take effect on the date of adoption.

Main Market current trading session data| last update 16:55

Indices

WIG20
4,239.55 1.45%
mWIG40
10,615.45 2.83%
WIG
159,138.85 1.75%
Biggest price increase

TRITON
3.8600 13.53%
SATIS
0.2800 12.00%
PBSFINANSE
0.6600 10.00%
Biggest price decrease

VIVID
0.2900 30.95%
SOHODEV
0.1110 17.78%
XTB
115.8000 17.12%
Most active

XTB
115.8000 389,284,144
ALLEGRO
66.9000 278,118,861
PKOBP
118.7800 158,204,592